Lausanne hospital test chosen for coronavirus study
A Covid-19 antibody test developed at Lausanne university hospital (CHUV) has been chosen for wide-scale studies of the Swiss population, the hospital has announced.
This content was published on
1 minute
Keystone-SDA/jc
Selection of a single serology test was necessary for consistent and comparable data at national level, CHUV said on Thursday.
The hospital announced in June that one of its teams had developed a new coronavirus antibody blood test in collaboration with the Federal Institute of Technology Lausanne (EPFL) and the Swiss Vaccine Research Institute.
“Compared to other commercially available tests, the technology developed at the CHUV has a 15-30% higher sensitivity, making it possible to detect antibodies to SARS-CoV-2 long after infection, even in people with few or no symptoms,” CHUV said in a press release.
Corona Immunitas, the government-backed antibody testing programme, has now chosen it for nationwide tests. Supported by the Federal Office of Public Health (FOPH), Corona Immunitas is in charge of coordinating more than 20 population studies to estimate the number of people infected with SARS-CoV-2 in Switzerland.
Such studies are very useful from an epidemiological point of view and may also help determine immunity levels to the virus.
Swiss money laundering office registers record number of reports
This content was published on
The Money Laundering Reporting Office Switzerland (MROS) registered a record number of reports of suspicious activity last year.
Two teens accused of planning terror attack released from custody
This content was published on
The Schaffhausen judiciary has released the two teenagers from custody who allegedly planned bomb attacks in Switzerland.
OECD: Sluggish economic activity slowing growth in Switzerland
This content was published on
Sluggish economic activity at the start of the year is weighing on growth in Switzerland, with GDP expected to fall to 1.1% in 2024.
Report finds mistakes which led to Swiss government data breach
This content was published on
Mistakes were made by both the government and internet company Xplain in the case of a criminal cyber-attack on the Bern-based IT business.
Swiss government wants better gender balance in federal administration
This content was published on
New Swiss government personnel management targets say there must be even more female managers in the federal administration.
Swiss national science foundation funded over 5,000 projects in 2023
This content was published on
In 2023, the Swiss National Science Foundation (SNSF) provided a total of CHF961 million worth of funding towards research projects.
Switzerland invites 160 delegations to June Ukraine peace talks
This content was published on
Russia is currently not among the delegations invited to talks aimed at helping bring about peace in the conflict between Moscow and Ukraine.
Survey: air travel most popular way to go on holidays for Swiss
This content was published on
Despite the climate crisis, flying is the most popular mode of transport for private travel – particularly among young, urban and high-income travellers.
Swiss government to use phone data to identify asylum seekers
This content was published on
From April 2025, authorities plan to be able to analyse data from mobile phones, computers and other data carriers to identify asylum seekers.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland mulls controversial Covid-19 health passports
This content was published on
Swiss technology firms and medical researchers are developing digital health passports that could be used to certify who is immune to Covid-19.
Roche in talks with Britain on Covid-19 antibody test
This content was published on
Britain is in talks with Swiss drugmaker Roche on rolling out an accurate Covid-19 antibody test that it said could be a game changer.
This test could help Switzerland get back on track
This content was published on
While we await a vaccine or treatment, scientists are developing tests to tell us how widespread the virus is, such as the serological test.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.